Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coherus Oncology (CHRS) Tax Rate (2019 - 2023)

Coherus Oncology (CHRS) has disclosed Tax Rate for 3 consecutive years, with 0.95% as the latest value for Q3 2023.

  • Quarterly Tax Rate changed N/A to 0.95% in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 0.16% through Dec 2023, changed N/A year-over-year, with the annual reading at 0.16% for FY2023, N/A changed from the prior year.
  • Tax Rate hit 0.95% in Q3 2023 for Coherus Oncology, down from 12.26% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 12.26% in Q4 2020 to a low of 0.22% in Q2 2019.
  • Historically, Tax Rate has averaged 3.18% across 3 years, with a median of 1.96% in 2019.
  • Biggest YoY gain for Tax Rate was 739bps in 2020; the steepest drop was -112bps in 2020.
  • Year by year, Tax Rate stood at 4.87% in 2019, then skyrocketed by 152bps to 12.26% in 2020, then plummeted by -92bps to 0.95% in 2023.
  • Business Quant data shows Tax Rate for CHRS at 0.95% in Q3 2023, 12.26% in Q4 2020, and 0.65% in Q3 2020.